APA (7th ed.) Citation

Bessoles, S., Chiron, A., Sarrabayrouse, G., De La Grange, P., Abina, A. M., & Hacein‐Bey‐Abina, S. (2024). Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple‐negative breast cancer. Immunology, 173(2), 360. https://doi.org/10.1111/imm.13832

Chicago Style (17th ed.) Citation

Bessoles, Stéphanie, Andrada Chiron, Guillaume Sarrabayrouse, Pierre De La Grange, Amine M. Abina, and Salima Hacein‐Bey‐Abina. "Erythropoietin Induces Tumour Progression and CD39 Expression on Immune Cells in a Preclinical Model of Triple‐negative Breast Cancer." Immunology 173, no. 2 (2024): 360. https://doi.org/10.1111/imm.13832.

MLA (9th ed.) Citation

Bessoles, Stéphanie, et al. "Erythropoietin Induces Tumour Progression and CD39 Expression on Immune Cells in a Preclinical Model of Triple‐negative Breast Cancer." Immunology, vol. 173, no. 2, 2024, p. 360, https://doi.org/10.1111/imm.13832.